Alan
French digital health insurer combining licensed coverage with an app for care and prevention.
Alan sits on a license few can get and a growing member base, with the real test being whether group profits arrive by 2027 before a big insurer ships a real competing product.
Alan is a health insurance company that started fresh in France in 2016 and Canada more recently, rather than being bought or inherited from an older company. It sells insurance to individuals and groups, and uses software to handle claims and customer service faster than older insurers do. The hard part for competitors is that governments do not easily hand out new insurance licenses, so Alan had a rare opening that older insurers like AXA and Allianz cannot simply recreate by themselves, though those large companies could theoretically launch their own new brand if they chose to. Alan is already profitable in France and has over one million customers, which means it is a real operating business, not just an idea. The one thing that could change everything is whether Alan can turn its whole company profitable by 2027, not just individual countries, and whether the big established insurers actually launch a serious rival product that takes away customers.
AXA, Allianz, or Generali launch a digital-native insurance product competing directly with Alan. Would show incumbents are shipping a real rival, not just talking about digital transformation.
French financial regulators approve or delay Alan's €480M Series G closing. Confirms whether Alan's latest funding and valuation actually finalize as announced.
- €785M ARR, up 53% year over year
- 1.1M+ members across 37,000+ businesses
- €480M Series G at €5.5bn valuation
- Group-level profitability still unproven, targeted for 2027 while France alone is profitable.
- Series G closing subject to French financial regulatory approval as of June 25, 2026.
- Headcount figures across Alan's own disclosures and third-party data are unreconciled, clouding scale claims.
- Reputational spillover risk from CEO's ties to Mistral AI amid Mistral's competitive pressure from DeepSeek and pricing wars in 2026.
- Sector-wide French/EU reimbursement reform could compress insurer margins broadly.
| Rival | Direction | Evidence |
|---|---|---|
| AXA, Allianz, Generali | gaining on | Alan grew ARR 53% YoY to €785M by end-2025 while incumbents have not shipped a competing digital-native product |
| Wakam | gaining on | Wakam needed €85M recapitalization in 2025 plus €34M in early 2026 with SCR below ACPR requirements, while Alan raised €480M in June 2026 |
| Wefox, Qover | contesting | Cited as embedded insurance/platform competitors in SME and broker channels, per vendor-style competitive analysis, March 2026 |
| Sanitas (Bupa/Blua) | contesting | Described as a strong digital-first rival in Spain, one of Alan's expansion markets, per March 2026 secondary source |
- Is Alan profitable in 2026?
- Alan says it is operationally profitable in France, its largest market, as of March 2026, while group-level break-even is targeted for 2027. Net loss was $56M in 2024, down from $61M in 2023, per company-reported figures cited March 11, 2026.
- How much funding has Alan raised?
- Alan has raised roughly $1.3B across nine rounds as of June 2026, including a €480M Series G led by Prosus announced June 25, 2026, valuing the French health insurer at about €5.5bn ($6.3bn).
- Could AI replace Alan's insurance business?
- No. Alan holds an ACPR-regulated French insurance license, the first new one since 1986, and an OSFI federal license in Canada, the first new carrier there in about 70 years. Regulated risk-bearing and capital requirements block pure AI or software entrants from replicating this.
- Who is Alan's biggest competitor?
- Alan names no shipped rival taking share; large incumbents AXA, Allianz and Generali are cited as slow-moving adjacent competitors (vendor-claimed, March 2026), while peer insurtech Wakam has instead shown financial distress with recapitalizations in 2025 and 2026.
- Who owns Alan?
- Alan is privately held; founders and employees hold roughly 40% of capital and majority voting rights as of late 2025. Investors include Prosus, Index Ventures, Belfius, and Ontario Teachers', following a €480M Series G announced June 25, 2026.
- What is Alan's revenue in 2026?
- Alan reported (company-stated) €785M ARR for full-year 2025, up 53% year over year, with Q1 2026 ARR exceeding €800M at the same growth rate, and a target of about €1B ARR ($1.16B) by end of 2026.
- 2026-06-25Alan announces €480M Series G led by Prosus, valuing it at €5.5bn, pending French regulatory approval
- 2026-06-24Alan reports 1.1M+ members across 37,000+ businesses
- 2026-03-20Alan reported reaching a $5.83bn valuation per Beinsure
- 2026-03-12Alan targets €1B ARR by end of 2026
- 2026-03-11Alan raises €100M ($116M) led by Index Ventures at €5bn valuation, cites France profitability
- 2026-01Alan launches French-first Quebec employer offering in Canada
- 2025-12-31Alan headcount reaches ~1,196 employees globally per Revelio Labs, +11% YoY
- 2024-12-31Alan closes €140M Series F at €4bn valuation, led by Belfius; net loss $56M for the year
- 2024-12-31Alan receives OSFI federal license, becoming first new Canadian health carrier in ~70 years
- Health insurtech Alan reaches $5.83 bn valuation (2026-03-20)
- Alan announces a €480 million financing round (2026-06-25)
- Health insurance startup Alan reaches €5B valuation (2026-03-11)
- Alan valued at €5bn after €100m funding round (2026-03-12)
- Health unicorn Alan raises €480m Series G round led by Prosus (2026-06-24)
- How a Paris startup is shaking up Europe's insurance game (2026-03-11)
- Alan announces a €480 million financing round (2026-06-25)
- Analysing Prosus's €400 Million Investment in Alan (2026)
- Careers at Alan
- Employee Count & Headcount Data (2026-06-29)
- 2024 Q4 Letter to Shareholders (2025-10-28)
- Mistral's origin story has an insurtech founder at its heart (2025-01-27)